Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
What are the implications of a VP shunt located in the radiation field in a patient receiving treatment for breast cancer?
Should the VP shunt be moved prior to RT? Are there any complications of radiating a VP shunt?
Answer from: Radiation Oncologist at Community Practice
I don’t see any contradiction to RT here.
Sign in or Register to read more
7934
Related Questions
What is your preferred sequencing of adjuvant chemotherapy and PMRT for node + breast cancer?
How do you respond to a patient who asks "Why do I still need breast radiation after chemotherapy if chemotherapy treats the whole body?"
Is DCISionRT appropriate for multifocal DCIS?
How do you choose between ALND and RNI in the setting of LYMPHA or S-Lympha surgery?
Do you prefer to use the FAST or FAST-Forward regimen when treating stage I breast cancer with an ultra-hypofractionated approach?
Should PMRT be offered for ypN0(i+) disease if only 1-2 nodes were removed in the post-chemotherapy SLNB and there is no plan for a completion AxLND?
Would you offer ultra-hypofractionated accelerated partial breast re-irradiation using 5 fractions?
Is there any increased risk with adjuvant breast radiation for a patient with muscular dystrophy?
Would you recommend PMRT to a clinically node positive (biopsy proven axillary node and indeterminate single IMN node) BRCA positive patient with multiple medical co-morbidities including scleroderma and ILD who is treated with neoadjuvant chemotherapy (NAC) and mastectomy who converts to ypT0/ypN0?
Does radiation therapy (ex. to the breast) in patients with CDK4 mutations increase the risk of developing melanoma?